TTRXTurn Therapeutics Inc.

Healthcare
$6.82

The financials

Turn Therapeutics Inc. by the numbers

The next results filing is expected around Nov 12, 2026, the same week as a year ago.

Turn Therapeutics Inc. income statement, Q2 2026 against the same quarter a year earlier
Income statementQ2 2026Q2 2025Change
Operating income−$1.6M−$1.4Mn/a
Net income−$5.8M−$1.2Mn/a
Diluted EPS−$0.20−$0.05n/a

Biotechnology

The closest names by size in the same industry

Compare peers
OBIO+0.88%
Orchestra BioMed Holdings, Inc.
OCGN-1.8%
Ocugen, Inc.
RLMD-2.9%
RELMADA THERAPEUTICS, INC.
ENTA-2.2%
ENANTA PHARMACEUTICALS INC
ARTV-2.9%
Artiva Biotherapeutics, Inc.
SRZN+12%
Surrozen, Inc./DE